Active Not RecruitingNCT06373731
ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)
PHASE3 · 313 planned enrolment
- Countries listed
- 8
- Registry update
- September 17, 2026
